Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 12:47 PM
Ignite Modification Date:
2025-12-24 @ 12:47 PM
NCT ID:
NCT02783261
Eligibility Criteria:
Inclusion Criteria:
* All patients with HCC who are to receive SIRT
* The diagnosis of HCC is made based on current diagnostic criteria i.e. a characteristic appearance on contrast-enhanced quadriphasic CT scan and/or MRI, raised serum AFP levels and the presence of known risk factors
* Patients with tumor confined in the right/left lobe who will receive unilobar SIRT to the right/left hepatic artery
* All adult patients above 21 are eligible for the study
* Able to provide informed consent
Patients must meet all the above inclusion criteria to be enrolled into the study
Exclusion Criteria:
Any patient with the following exclusion criteria will not be eligible for the study:
* Patients who received SIRT not confined to the left or right lobe
* Patients who received other concomitant treatment
* Patients with bilobar disease at the time of treatment
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
21 Years
Maximum Age:
99 Years
Study:
NCT02783261
Study Brief:
Protocol Section:
NCT02783261